Antibacterial drug discovery: challenges and preclinical promises from synthetic small molecules
{{output}}
Over the past few decades, antibacterial discovery has changed substantially, yet innovation has remained slow despite the growing need for new agents active against multidrug-resistant pathogens. Progress is constrained by scientific hurdles, including target... ...
